≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Other parts of oropharynx

DOID Endpoint Browser PheWeb

CD2_BENIGN_OROPHA_OTHER

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D10.5&
  • Hospital discharge: ICD-9 — 2106
  • Hospital discharge: ICD-8 — 2106
  • Cause of death: ICD-10 — D10.5&
  • Cause of death: ICD-9 — 2106
  • Cause of death: ICD-8 — 2106

2 out of 7 registries used, show all original rules.

338

4. Check minimum number of events

None

338

5. Include endpoints

None

338

6. Filter based on genotype QC (FinnGen only)

325

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10
Name in latin
Neoplasma benignum oropharyngis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2025 1071 939
Only index persons 1865 1002 863
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.03
Only index persons 0.04 0.04 0.03
Median age at first event (years)
Whole population 51.53 52.28 50.52
Only index persons 50.66 51.48 49.72

-FinnGen-

Key figures

All Female Male
Number of individuals 325 192 133
Unadjusted period prevalence (%) 0.07 0.07 0.06
Median age at first event (years) 53.46 51.83 55.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
338
Matched controls
3380
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
+∞
307.7
321
*
ENA10
NOMESCO Finland
Biopsy of pharynx
139.3
46.1
48
*
UJC01
NOMESCO Finland
Scopy of lower throat
27.9
24.5
33
13
EHA10
NOMESCO Finland
Biopsy of palate
61.4
20.2
23
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.8
18.0
44
103
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
19.7
16.3
24
13
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
167.4
15.6
16
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
30.2
15.4
20
7
EHB00
NOMESCO Finland
Excision of lesion of palate
31.3
11.7
15
5
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.8
10.8
35
101
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
11.1
10.4
19
18
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
24.2
10.3
14
6
R07.0
ICD-10 Finland
Pain in throat
3.5
10.2
36
110
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.3
9.6
39
130
WX402
NOMESCO Finland
General anaesthesia
2.3
9.1
86
442
J39.2
ICD-10 Finland
Other diseases of pharynx
13.0
8.9
15
12
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
9.9
8.9
17
18
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
51.3
8.7
10
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
13.2
8.4
14
11
G47.3
ICD-10 Finland
Sleep apnoea
2.1
8.3
92
502
J35.0
ICD-10 Finland
Chronic tonsillitis
3.6
8.0
27
80
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
46.1
7.7
9
*
GBB00
NOMESCO Finland
Tracheostomy
12.2
7.6
13
11
WZC00
NOMESCO Finland
Treatment plan or consultation
1.9
7.5
133
854
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
81.8
7.4
8
*
R21
ICPC
Throat symptom/complaint
2.1
7.3
85
469
21068
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Other parts of oropharynx
+∞
7.3
7
*
2106A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Other parts of oropharynx
+∞
7.3
7
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
16.2
7.3
11
7
EMA10
NOMESCO Finland
Biopsy of tonsil
20.5
7.2
10
5
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
7.8
7.0
15
20
ZXE00
NOMESCO Finland
One hour or less
1.8
6.8
139
928
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
23.0
6.7
9
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
5.5
6.6
18
34
Z2221
NOMESCO Finland
Medical doctor
1.9
6.4
100
609
WF002
NOMESCO Finland
Radical radiotherapy
3.3
6.4
24
76
130
Kela drug reimbursment
Malignant tumour
2.6
6.4
38
157
R52.9
ICD-10 Finland
Pain, unspecified
2.5
6.2
42
185
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
12.8
6.1
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
193
1138
2.62
16.75
2.4
2.0
—
—
—
0
0
172
1150
2.01
9.02
5.6
4.7
35.61
35.88
g/l
0.25
163
1090
55
249
2.44
7.65
1.4
1.4
—
—
—
0
0
265
2171
2.02
6.62
8.3
7.5
76.91
77.96
u/l
0.18
253
2029
210
1624
1.77
5.98
9.4
9.4
4.21
4.04
e9/l
0.56
177
1428
180
1333
1.75
5.96
6.1
6.2
—
—
—
0
0
61
321
2.10
5.89
2.1
1.6
—
—
—
0
0
191
1451
1.73
5.66
6.3
6.0
0.20
0.19
e9/l
0.37
166
1286
176
1313
1.71
5.53
8.7
7.2
1.22
1.21
mmol/l
0.52
151
1114
208
1626
1.73
5.48
6.0
4.9
6.60
6.58
mmol/l
0.04
192
1504
171
1268
1.71
5.47
5.9
5.9
0.71
0.68
%
0.23
159
1189
179
1344
1.71
5.47
2.7
2.6
—
—
—
0
0
260
2176
1.84
5.30
4.7
3.9
14.71
14.69
pmol/l
0.05
234
1977
175
1315
1.69
5.26
5.8
5.8
2.60
2.84
%
0.79
162
1242
167
1242
1.68
5.20
17.1
11.4
1.26
1.20
inr
0.44
47
375
184
1406
1.68
5.15
5.7
5.6
0.04
0.04
e9/l
0.42
153
1223
175
1320
1.68
5.15
6.0
6.1
8.52
8.53
%
0.02
162
1250
29
117
2.62
5.11
1.3
1.2
—
—
—
0
0
183
1400
1.67
5.07
5.7
5.6
0.58
0.57
e9/l
0.20
153
1218
191
1485
1.66
4.91
6.8
6.2
10.90
10.93
umol/l
0.01
185
1414
129
911
1.67
4.80
3.9
3.5
2.35
2.35
mmol/l
0.07
115
816
233
1915
1.70
4.77
4.9
4.2
—
—
—
0
0
177
1357
1.64
4.75
5.9
5.9
26.63
28.30
%
1.14
164
1288
186
1448
1.63
4.67
5.7
5.7
1.93
1.99
e9/l
0.15
163
1296
36
169
2.26
4.60
3.7
3.9
4.51
4.61
pmol/l
0.24
29
150
249
2101
1.70
4.43
4.5
4.0
11.85
11.23
mm/h
0.27
233
1929
50
272
1.98
4.39
2.2
2.4
39.03
34.35
u/l
0.21
39
228
173
1341
1.59
4.29
5.8
5.7
59.07
56.99
%
1.54
160
1272
312
2837
2.30
4.19
20.2
13.6
21.35
22.51
mg/l
0.27
273
2225
109
767
1.62
3.98
3.0
3.0
0.64
0.39
e6/l
0.45
77
563
157
1208
1.56
3.90
7.5
6.4
1.22
1.21
mmol/l
0.09
145
1110
81
531
1.69
3.88
2.9
2.8
506.23
538.79
mosm/kgh2o
0.60
64
451
114
816
1.60
3.86
5.2
4.1
7.41
7.40
ph
0.70
24
155
91
616
1.65
3.86
1.8
1.7
1.87
1.19
mg/l
0.51
69
489
141
1061
1.56
3.85
2.1
1.9
91.52
95.08
pmol/l
0.49
68
550
115
832
1.58
3.70
1.4
1.4
—
—
—
0
0
63
390
1.76
3.70
1.4
1.2
—
—
—
0
0
314
2887
2.23
3.68
21.8
15.4
139.56
139.75
mmol/l
0.72
309
2803
34
173
2.07
3.59
3.0
2.1
—
—
—
0
0
314
2895
2.19
3.52
22.2
15.4
3.91
3.97
mmol/l
3.26
308
2809
229
1943
1.55
3.49
4.1
3.7
—
—
—
0
0
293
2642
1.82
3.49
5.7
4.6
1.98
2.31
mu/l
0.31
269
2415
111
808
1.56
3.44
4.3
3.7
—
—
—
0
0
39
213
1.94
3.40
4.8
2.8
66.94
66.70
g/l
0.07
39
193
76
508
1.64
3.35
3.5
3.4
137.34
307.41
ng/l
0.70
56
372
113
832
1.54
3.31
3.0
3.1
20.90
130.68
e6/l
0.78
84
628
171
1379
1.49
3.21
4.0
3.5
0.00
0.00
estimate
-0.00
39
252
141
1095
1.49
3.18
3.7
3.3
6.00
5.81
ph
0.30
11
86
168
1353
1.48
3.16
4.1
3.5
0.00
0.00
estimate
0.50
43
280
156
1238
1.48
3.16
11.2
9.4
0.00
0.00
e9/l
1.02
119
1013
279
2501
1.66
3.15
21.9
16.1
15.18
14.78
%
0.44
273
2468
103
752
1.53
3.11
3.1
2.9
—
—
—
0
0
168
1360
1.47
3.04
5.7
4.7
0.00
0.00
estimate
-0.00
40
259
55
351
1.68
2.89
2.0
1.4
—
—
—
0
0
318
2979
2.14
2.86
17.1
12.4
—
—
—
0
0
17
71
2.47
2.85
3.4
2.5
1.24
1.53
mg/l
1.25
17
64
226
1955
1.47
2.79
3.4
3.1
50.90
48.36
u/l
0.21
214
1836
80
567
1.54
2.73
2.4
2.5
5.31
4.81
e6/l
0.13
68
509
62
415
1.60
2.70
3.4
2.3
15.03
13.62
umol/l
0.69
55
384
70
487
1.55
2.59
1.8
1.7
—
—
—
0
0
125
979
1.44
2.59
3.7
3.7
82.16
65.85
e6/l
0.17
89
678
29
158
1.91
2.57
4.0
3.1
7.39
7.42
ph
—
5
18
14
56
2.56
2.56
1.4
1.7
—
—
—
0
0
20
95
2.17
2.54
1.6
1.5
—
—
—
0
0
141
1134
1.42
2.51
2.1
2.2
74.38
75.98
nmol/l
0.31
124
1017
321
3036
2.14
2.50
12.5
10.1
28.15
26.62
u/l
0.77
312
2926
70
491
1.54
2.50
3.7
2.8
2.44
2.45
mmol/l
0.14
61
435
117
917
1.42
2.38
2.8
2.5
57.93
62.37
u/l
0.33
107
845
116
908
1.42
2.38
2.8
2.3
—
—
—
0
0
54
361
1.59
2.37
1.9
1.6
—
—
—
0
0
95
717
1.45
2.37
5.2
4.5
—
—
—
0
0
91
684
1.45
2.31
7.1
7.1
—
—
—
0
0
49
323
1.60
2.28
8.1
7.6
103.24
104.09
mmol/l
0.53
49
323
55
376
1.55
2.20
3.6
2.2
2.29
2.32
g/l
0.21
49
349
35
215
1.70
2.14
3.2
4.4
0.60
0.50
%
—
10
66
22
117
1.94
2.11
3.7
3.1
—
—
—
0
0
8
25
3.25
2.11
4.6
2.4
—
—
—
0
0
26
147
1.83
2.09
10.3
11.7
—
—
—
0
0
9
31
2.95
2.08
1.4
1.3
—
—
—
0
0
5
10
5.06
2.08
1.0
1.1
—
—
—
0
0
282
2603
1.50
2.07
6.1
5.4
40.06
39.53
mmol/mol
0.42
259
2430
98
761
1.41
2.06
3.6
3.1
—
—
—
0
0
148
1231
1.36
2.05
3.6
2.7
135.88
119.39
ug/l
0.31
135
1137
9
32
2.86
2.01
1.9
1.3
122.78
0.47
nmol/l
—
9
27
67
487
1.47
2.01
1.8
1.6
1445.11
1216.93
nmol/l
0.99
44
366
79
594
1.43
1.99
2.2
1.9
—
—
—
0
0
8
27
3.01
1.95
1.1
1.3
—
—
—
0
0
6
16
3.80
1.94
1.0
1.8
—
—
—
0
0
22
121
1.88
1.93
2.3
2.3
—
—
—
0
0
294
2748
1.54
1.92
5.0
4.3
6.01
5.91
mmol/l
0.73
268
2528
97
761
1.39
1.91
1.7
1.7
1.58
1.38
mmol/l
0.82
83
652
35
222
1.64
1.91
3.5
4.6
0.00
0.12
%
—
10
65
83
635
1.41
1.89
1.3
1.2
0.56
1.61
u/ml
1.75
19
166
50
347
1.52
1.88
1.3
1.3
—
—
—
0
0
11
46
2.44
1.87
2.2
3.2
—
—
—
0
0
6
17
3.57
1.84
5.2
2.7
—
—
—
0
0
37
241
1.60
1.83
3.5
4.4
1.09
0.90
%
0.18
11
85
16
81
2.02
1.78
4.4
3.0
—
—
—
0
0
101
807
1.36
1.77
2.3
2.1
168.99
277.33
u/l
0.65
90
763
55
395
1.47
1.76
2.3
2.2
—
—
—
0
0
8
30
2.71
1.73
1.9
1.3
—
—
—
0
0
7
24
2.96
1.73
2.0
1.0
—
—
—
0
0
31
196
1.64
1.73
1.4
1.5
—
—
—
0
0
41
279
1.53
1.69
2.5
4.4
3.97
23.74
ug/l
0.70
32
228
30
190
1.64
1.67
1.2
1.2
—
—
—
0
0
327
3158
2.09
1.64
28.0
19.9
249.17
250.80
e9/l
0.17
321
3083
17
91
1.91
1.63
1.0
1.2
—
—
—
0
0
327
3159
2.08
1.63
28.3
20.0
39.87
40.42
%
0.75
306
2975
8
32
2.54
1.60
1.3
1.3
—
—
—
0
0
33
217
1.58
1.58
10.3
9.5
—
—
—
0
0
16
85
1.93
1.57
2.6
3.5
71.55
120.93
mg/l
0.29
11
68
327
3162
2.05
1.57
28.0
19.9
4.48
4.51
e12/l
0.42
318
3081
53
387
1.44
1.56
1.3
1.4
660.00
480.00
titre
0.21
14
85
327
3163
2.04
1.55
28.1
19.9
6.98
6.65
e9/l
1.68
319
3080
100
814
1.32
1.53
4.8
3.7
3.53
9.86
mg/mmol
3.51
67
508
11
51
2.20
1.52
2.8
2.4
16.42
15.85
%
—
6
21
69
531
1.38
1.52
1.6
1.7
449.86
449.74
pmol/l
0.00
50
452
12
58
2.11
1.51
2.7
4.1
—
—
—
0
0
9
37
2.47
1.49
1.1
1.2
—
—
—
0
0
58
435
1.40
1.48
2.9
2.9
1.79
2.33
e6/l
0.20
28
221
25
156
1.65
1.48
1.2
1.3
—
—
—
0
0
32
213
1.55
1.47
3.7
4.7
0.00
0.02
%
—
7
57
295
2791
1.45
1.47
4.8
4.2
1.41
1.47
mmol/l
1.74
272
2588
35
238
1.52
1.47
8.1
7.6
1.45
1.23
mmol/l
0.55
35
233
7
28
2.53
1.46
2.0
1.3
—
—
nmol/l
—
0
0
88
709
1.33
1.44
2.8
2.8
9923.65
8217.88
umol/l
0.09
77
626
37
257
1.49
1.41
8.6
10.6
119.76
120.88
g/l
0.13
37
251
30
199
1.56
1.40
1.2
1.2
97.50
138.92
iu/ml
—
6
71
95
777
1.31
1.39
4.0
3.2
567.52
224.58
mg/l
0.27
64
503
48
353
1.42
1.37
3.7
2.3
25.78
23.72
%
0.51
39
304
296
2810
1.43
1.36
4.9
4.3
4.65
4.69
mmol/l
0.22
277
2622
14
75
1.90
1.36
2.0
1.8
5.17
6.97
iu/l
—
6
28
11
54
2.07
1.34
2.8
3.1
3.26
4.43
e9/l
1.92
11
54
31
210
1.52
1.33
1.8
2.4
2.42
5.92
ug/l
4.72
22
192
9
43
2.12
1.31
1.9
1.7
—
—
—
0
0
8
34
2.39
1.30
1.0
1.2
216.00
369.59
pmol/l
—
8
34
11
55
2.03
1.28
3.0
3.6
55.55
57.76
%
0.21
11
55
102
851
1.28
1.28
3.8
3.0
7.80
7.76
mmol/l
0.03
88
716
91
749
1.29
1.27
4.3
3.8
0.00
0.00
estimate
-0.00
39
258
38
273
1.44
1.24
8.8
10.1
95.86
95.77
%
0.05
38
265
7
142
0.48
1.24
1.3
1.7
—
—
—
0
0
36
257
1.45
1.22
2.3
1.8
384.31
371.09
nmol/l
0.16
36
236
5
19
2.66
1.22
2.0
1.4
0.82
1.05
g/l
—
5
19
19
117
1.66
1.21
1.5
1.6
—
—
—
0
0
6
26
2.33
1.19
1.8
1.5
—
—
—
0
0
34
244
1.44
1.13
4.7
3.5
—
—
—
0
0
5
21
2.40
1.09
1.0
1.3
1.92
1.81
mmol/l
—
5
21
7
32
2.21
1.08
1.0
1.2
—
—
—
0
0
298
2855
1.37
1.07
5.5
4.8
2.80
2.79
mmol/l
0.12
277
2642
7
33
2.14
1.06
2.4
1.8
—
—
—
0
0
122
1062
1.23
1.05
5.1
3.6
20.05
39.97
ng/l
2.64
79
715
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
7
34
2.08
1.03
1.9
1.6
30.14
32.59
pg
—
7
34
9
47
1.94
1.03
1.4
1.3
—
—
—
0
0
10
53
1.91
1.02
3.3
2.3
—
—
—
0
0
32
232
1.42
1.02
1.5
1.5
—
—
—
0
0
94
799
1.24
1.00
3.3
2.7
—
—
—
0
0
30
216
1.43
0.99
2.3
2.4
67.25
73.56
e9/l
0.52
22
165
7
37
1.91
0.94
1.0
2.5
—
—
—
0
0
36
271
1.37
0.94
1.7
1.5
—
—
—
0
0
6
27
2.24
0.94
1.0
1.2
0.37
1.24
promille
—
6
20
30
219
1.41
0.93
1.1
1.1
—
—
—
0
0
15
95
1.61
0.89
4.8
10.0
2.11
1.55
%
0.58
15
88
74
621
1.25
0.88
3.9
3.5
—
—
—
0
0
38
292
1.34
0.88
1.7
2.7
1.97
1.88
%
0.23
30
266
8
43
1.88
0.88
5.4
2.4
—
—
—
0
0
6
30
2.02
0.87
1.2
3.3
—
—
—
0
0
282
2704
1.26
0.83
4.4
3.8
1.39
1.28
mmol/l
1.72
259
2493
70
590
1.24
0.81
1.7
1.4
2.92
2.38
g/l
0.55
45
369
10
58
1.75
0.80
1.3
1.3
—
—
—
0
0
30
226
1.36
0.79
3.9
3.4
—
—
—
0
0
6
33
1.83
0.79
3.8
3.3
2.37
2.99
nmol/l
—
6
33
14
90
1.58
0.79
5.0
10.5
0.85
0.91
%
0.34
14
84
21
289
0.71
0.77
1.3
1.3
—
—
—
0
0
33
254
1.33
0.77
4.1
4.4
—
—
—
0
0
42
335
1.29
0.76
2.1
1.7
—
—
—
0
0
28
211
1.36
0.75
1.7
2.2
9.71
13.18
nmol/l
1.53
23
194
5
24
2.10
0.75
1.2
1.7
—
—
—
0
0
5
24
2.10
0.75
4.6
2.1
29.57
16.80
ug/l
—
5
24
44
355
1.28
0.74
1.9
2.3
90.83
135.27
ug/g
0.78
37
282
7
38
1.86
0.74
1.7
1.3
—
—
—
0
0
7
39
1.81
0.73
2.0
3.3
—
—
—
0
0
7
41
1.72
0.70
5.9
3.0
—
—
—
0
0
5
27
1.86
0.68
1.2
1.0
—
—
—
0
0
14
95
1.49
0.65
3.5
2.7
—
—
—
0
0
26
199
1.33
0.64
3.8
4.0
75.35
83.95
ng/l
0.29
26
180
6
104
0.57
0.63
4.8
9.3
—
—
—
0
0
59
503
1.21
0.62
1.2
1.3
19.12
31.09
iu/ml
0.72
12
167
0
23
0.00
0.58
0.0
1.1
—
0.73
—
0
8
6
35
1.73
0.58
1.0
1.9
90.37
89.83
%
—
6
35
11
73
1.52
0.57
1.5
1.3
—
—
—
0
0
18
133
1.37
0.56
1.1
1.1
—
—
—
0
0
9
62
1.46
0.53
1.1
1.2
—
—
—
0
0
6
40
1.51
0.52
1.5
1.1
—
—
—
0
0
26
208
1.27
0.49
1.9
2.6
3.83
7.02
e9/l
0.97
18
179
7
46
1.53
0.48
1.4
1.1
—
—
—
0
0
7
48
1.47
0.47
1.1
1.0
—
—
—
0
0
14
103
1.37
0.46
1.5
1.3
—
3.35
—
0
8
40
340
1.20
0.45
1.2
1.3
—
—
—
0
0
13
95
1.38
0.44
1.6
1.4
325.45
261.96
miu/ml
—
5
49
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
92
839
1.13
0.44
4.8
4.5
1.79
2.16
ug/l
0.55
79
753
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
8
59
1.36
0.41
5.1
3.0
—
—
—
0
0
8
60
1.34
0.40
2.0
1.6
—
—
—
0
0
7
101
0.69
0.40
5.6
4.3
—
—
—
0
0
69
623
1.14
0.38
1.7
1.5
20.41
20.55
nmol/l
0.03
62
538
9
69
1.31
0.37
2.6
3.3
40.11
36.22
umol/l
—
9
60
5
37
1.36
0.37
1.4
2.8
—
—
—
0
0
5
37
1.36
0.37
1.4
2.8
4.16
4.06
mmol/l
—
5
37
5
37
1.36
0.37
1.4
2.8
108.00
105.73
mmol/l
—
5
37
36
312
1.17
0.35
1.8
1.7
—
—
—
0
0
72
657
1.12
0.34
2.5
2.0
2.49
3.05
mg/l
2.04
62
562
7
53
1.33
0.31
4.7
14.8
9.57
10.98
mmol/l
—
7
47
7
53
1.33
0.31
4.7
14.8
103.29
105.23
mmol/l
—
7
47
18
148
1.23
0.30
1.9
3.0
0.35
0.13
e6/l
0.40
18
143
7
56
1.26
0.29
1.3
1.6
—
—
—
0
0
7
57
1.23
0.29
1.1
1.1
—
—
—
0
0
12
94
1.29
0.28
1.3
1.2
6.02
9.19
u/l
—
7
75
10
76
1.33
0.28
1.1
1.2
—
—
—
0
0
8
63
1.28
0.28
2.6
1.4
—
—
—
0
0
15
182
0.82
0.27
2.7
2.3
—
—
—
0
0
9
77
1.17
0.24
9.7
12.0
1.14
1.25
mmol/l
—
9
65
9
77
1.17
0.24
1.3
1.8
—
—
—
0
0
12
97
1.25
0.23
1.5
1.3
—
—
—
0
0
5
41
1.22
0.22
1.2
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
4.7
—
5.86
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
6
50
1.20
0.20
6.8
3.4
6.88
7.42
mmol/l
—
6
50
7
61
1.15
0.17
1.4
1.3
—
—
—
0
0
6
80
0.75
0.15
1.3
1.3
—
2.64
—
0
14
9
82
1.10
0.15
1.2
1.5
—
—
—
0
0
9
82
1.10
0.15
1.2
1.5
—
—
—
0
0
9
83
1.09
0.14
1.4
1.6
—
—
—
0
0
15
131
1.15
0.14
2.5
2.5
0.78
0.66
%
0.58
15
131
8
99
0.80
0.14
1.3
1.5
—
—
—
0
0
10
117
0.85
0.13
1.2
1.6
—
—
—
0
0
52
495
1.06
0.11
1.2
1.3
6.78
8.47
u/ml
0.16
17
195
15
135
1.12
0.10
3.1
2.5
1.52
1.32
%
0.25
15
135
17
155
1.10
0.09
5.7
3.6
129.88
130.10
g/l
0.01
17
155
15
165
0.90
0.09
3.8
7.1
—
—
—
0
0
5
63
0.79
0.08
1.2
1.9
99.00
226.24
pmol/l
—
5
58
8
76
1.05
0.07
7.2
4.2
—
—
—
0
0
109
1079
1.02
0.02
3.3
2.7
—
—
—
0
0
62
610
1.02
0.02
4.6
3.6
1.02
1.02
kg/l
—
9
80
14
133
1.05
0.01
5.1
3.2
—
—
—
0
0
12
114
1.05
0.00
2.9
2.4
418.48
3710.12
u/l
—
5
40
11
109
1.01
0.00
1.2
1.6
—
—
—
0
0
49
488
1.00
0.00
2.7
2.8
0.69
0.74
ug/l
0.25
31
307
29
291
1.00
0.00
1.5
1.4
—
—
—
0
0
16
157
1.02
0.00
7.6
10.2
26.33
24.92
mmol/l
0.93
16
149
12
115
1.05
0.00
5.0
3.8
26.68
24.88
mmol/l
1.04
12
115
12
125
0.96
0.00
1.0
1.1
—
—
—
0
0
12
116
1.04
0.00
1.2
1.6
—
—
—
0
0
12
116
1.04
0.00
1.2
1.6
—
—
—
0
0
12
116
1.04
0.00
1.2
1.6
—
—
—
0
0
20
196
1.02
0.00
1.4
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
1493.56
—
0
9
0
9
0.00
0.00
0.0
3.8
—
54.06
—
0
9
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
1.60
—
0
7
6
59
1.02
-0.00
2.7
4.5
17.67
25.33
mg/l
—
6
36
0
6
0.00
-0.00
0.0
1.0
—
3.37
—
0
6
6
69
0.87
-0.00
2.7
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
10944.80
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
8
83
0.96
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
30.29
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
14.76
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_OROPHA_OTHER and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_OROPHA_OTHER 1.256 [0.99, 1.6] 0.063
Birth year 0.996 [0.99, 1.01] 0.452

During the follow-up period (1.1.1998 — 31.12.2019), 117 out of 834 females with CD2_BENIGN_OROPHA_OTHER died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_OROPHA_OTHER 1.677 [1.28, 2.2] < 0.001
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 137 out of 733 males with CD2_BENIGN_OROPHA_OTHER died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_OROPHA_OTHER.

N-year risk Females Males
1 0.14% 0.328%
5 0.857% 1.893%
10 2.044% 4.924%
15 3.593% 9.149%
20 6.503% 14.734%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_OROPHA_OTHER – Benign neoplasm: Other parts of oropharynx

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data